Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study
about
The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatmentsMechanism-Oriented Therapy of Irritable Bowel SyndromeGut microbiota as potential orchestrators of irritable bowel syndromeWhat is the therapeutic mechanism of the probiotics in irritable bowel syndrome patients with visceral hypersensitivity?Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome.Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysisProbiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndromeThe Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.Drug discovery approaches to irritable bowel syndrome.British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update).British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update).Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome.Editorial: The importance of systematic reviews and meta-analyses of probiotics and prebiotics.The Role of the Gastrointestinal Microbiota in Visceral Pain.Bifidobacterium longum and Lactobacillus helveticus Synergistically Suppress Stress-related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation.The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome.Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus.The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease.A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.Focus on the use of antidepressants to treat pediatric functional abdominal pain: current perspectives
P2860
Q26739291-E9C4155C-2302-4F19-B2DD-2973E155717AQ26747875-3FA5CA23-3AB2-424F-A2F4-21146E0A1D65Q28085584-248F0821-57BD-45EA-8699-5212ADF3643EQ34377233-B80641B9-430F-42B0-BA66-205DABCF6907Q35586987-9C74EF86-2B9F-4F20-8494-3A9208FC0BB6Q35867820-2D9E3F5B-8DAA-49CA-931D-E8B5B30066ECQ36050769-D0D5BF0C-77B0-4EE1-B4FE-EEF0C9485A87Q36211712-8405A9FF-88BC-4F3A-9ABC-63E2902001C1Q36347301-CE7A7170-E254-417D-BD21-2094C5044742Q36751990-0C4A13FD-AAD5-4672-A54A-178602AF7FCCQ37538949-9928C1D2-AB41-4159-B622-B4B849A82518Q38550878-06BAC1E1-C940-4197-8897-A99047CC9412Q38855986-1A278363-E779-47F6-8648-DD7F6161CAFBQ38858071-FF87AF3D-CEA8-4098-872E-20D223038FFEQ41172853-70A3AF37-B990-4F96-A1DE-52118E9FCF2FQ45978689-66F7D57E-36B9-49AF-A0C7-1E850470BEDEQ46438777-A6E455C8-3F12-4EE0-9ED2-824F546255ACQ47164662-FF0B9B1E-7112-41A8-B5E7-61BBA794A0BCQ49653059-1CC250BF-26EE-411D-930F-2C101393A0BDQ49822026-BCB9C0DD-973C-49FD-A73B-4D1846BBD6DCQ50300062-B002375F-E455-4C92-95CD-04CC58C43C5BQ54087826-FB8D266A-8563-4ED9-AD1F-91149DD4A82DQ55063629-BC44DB47-BE28-4BCE-8461-050D7057EF1BQ57489996-7715CE60-EFF3-453B-BBB5-A1AC910D6142
P2860
Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study
description
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2014
@ast
im Juli 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: July 2014)
@en
vedecký článok (publikovaný 2014-07)
@sk
vědecký článek publikovaný v roce 2014
@cs
wetenschappelijk artikel (gepubliceerd in 2014-07)
@nl
наукова стаття, опублікована в липні 2014
@uk
مقالة علمية (نشرت في يوليو 2014)
@ar
name
Randomised clinical trial: A l ...... --a 12 week double-blind study
@ast
Randomised clinical trial: A l ...... --a 12 week double-blind study
@en
Randomised clinical trial: A l ...... --a 12 week double-blind study
@nl
type
label
Randomised clinical trial: A l ...... --a 12 week double-blind study
@ast
Randomised clinical trial: A l ...... --a 12 week double-blind study
@en
Randomised clinical trial: A l ...... --a 12 week double-blind study
@nl
prefLabel
Randomised clinical trial: A l ...... --a 12 week double-blind study
@ast
Randomised clinical trial: A l ...... --a 12 week double-blind study
@en
Randomised clinical trial: A l ...... --a 12 week double-blind study
@nl
P2093
P2860
P3181
P356
P1476
Randomised clinical trial: A l ...... --a 12 week double-blind study
@en
P2093
I Bjarnason
R A Sherwood
P2860
P3181
P356
10.1111/APT.12787
P407
P50
P577
2014-07-01T00:00:00Z